Impact of Prior Drug Allergies on the Risk, Clinical Features, and Outcomes of Idiosyncratic Drug-Induced Liver Injury in Adults
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Background Prior drug allergies are common and may increase susceptibility to adverse medication effects. The aim of this study was to compare the frequency, clinical features, and outcomes of DILI among patients with and without a history of prior drug allergy.Methods The EMR at a large liver referral center was searched for all DILI encounters using ICD-10 T-codes for drug poisoning/toxicity and K-71 codes for toxic liver injury between 10/1/2015 and 9/30/2019. Clinically significant liver injury was identified using predefined laboratory criteria, and cases were adjudicated using a 5-point expert opinion scale: 1/2/3 = probable DILI and 4/5 = non-DILI. Drug allergy was defined as a history of anaphylaxis, hives, rash, or pruritus after drug exposure.Results Among 766,930 patient encounters, 127 unique patients met inclusion criteria with 72 (56.7%) cases adjudicated as probable DILI and 55 (43.3%) as non-DILI. In the probable DILI group, the most frequent suspect drug classes were: antimicrobials (41.9%), herbal and dietary supplements (9.5%), and antineoplastics (8.1%). Twenty-three of the 72 DILI patients (31.9%) had a history of drug allergy before the DILI episode compared to 16 (29.1%) of the 55 non-DILI cases (p = 0.89). However, none of the allergy drugs and suspect DILI drugs were the same although many were in the same drug class. DILI patients with a prior drug allergy were more likely to be female (73.9% vs. 44.9%, p = 0.04) and have lower serum bilirubin (4.0 vs. 7.8, p = 0.08) and INR (1.1 vs. 1.6, p = 0.043) levels at presentation. The likelihood of death or liver transplantation among probable DILI cases with prior drug allergy was lower than those without prior drug allergy (0% vs. 8.2%, p = 0.35). The suspect drug was subsequently documented in the "Drug Allergy" section of the EMR in only 23 (31.9%) of the 72 probable DILI patients, and these patients were more likely to present with a rash (7% vs. 2%, p = 0.006) and higher serum bilirubin levels (10.5 vs. 4.7, p = 0.008) compared to those in whom the suspect drug was not listed as "drug allergy."Conclusion A prior drug allergy history was not associated with a greater likelihood of developing DILI compared to other causes of acute liver injury. However, the probable DILI patients with a history of prior drug allergy tended to have less severe liver injury and clinical outcomes. The low rate of suspect drug documentation in the "Drug Allergy" section of EMR after a DILI episode is of concern and could lead to avoidable harm from inadvertent suspect drug re-challenge.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Overall, paracetamol accounted for a weighted mean of 55.7% (range 50.0-77.8%) of severe acute liver injury (ALI) and/or ALF [201-208] and 7.3% (range 1.2-29.2%) of drug-induced liver injury (DILI) [209-219] (see Figure 7).”
From Paracetamol (acetaminophen) overdose and hepatotoxicity: mechanism, treatment, prevention measures, and estimates of burden of disease (2023) · cites this paper as [218]
Citations
Cites
Incidence of Adverse Drug Reactions in Hospitalized Patients: A Meta-analysis of Prospective Studies
Lazarou, J., Pomeranz, B. H., & Corey, P. N. (1998) · JAMA · doi:10.1001/jama.279.15.1200 · Cited by 4,807
Adverse Drug Events in Ambulatory Care
Gandhi, T. K., Weingart, S. N., Borus, J., Seger, A. C., Peterson, J., Burdick, E., Seger, D. L., Shu, K., Federico, F., Leape, L. L., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmsa020703 · Cited by 1,345 · cited 3×
“ADRs are common, being reported in 15–25% of adult patients with serious reactions occurring in 7–13% of patients [2, 3].”
BackgroundClassen, D. C. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540280039031 · Cited by 1,134
Features and outcomes of 899 patients with drug-induced liver injury: the DILIN Prospective Study
Chalasani, N., Bonkovsky, H. L., Fontana, R., Lee, W., Stolz, A., Talwalkar, J., Reddy, K. R., Watkins, P. B., Navarro, V., Barnhart, H., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.03.006 · Cited by 925 · cited 2×
“The most frequent DILI suspect agents and the therapeutic drug classes identified in this study were similar to those reported in the Drug-Induced Liver Injury Network (DILIN) prospective study [23].”
BackgroundResultSelf-citationBjörnsson, E. S., Bergmann, O. M., Björnsson, H. K., Kvaran, R. B., & Olafsson, S. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.02.006 · Cited by 865
ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury
Chalasani, N. P., Hayashi, P. H., Bonkovsky, H. L., Navarro, V. J., Lee, W. M., & Fontana, R. J. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.131 · Cited by 860
Self-citationIncidence of Adverse Drug Reactions in Hospitalized Patients: A Meta-Analysis of Prospective Studies
LAZAROU, J., POMERANZ, B. H., & COREY, P. N. (1999) · Survey of Anesthesiology · doi:10.1097/00132586-199902000-00059 · Cited by 670
Which drugs cause preventable admissions to hospital? A systematic review
Howard, R. L., Avery, A. J., Slavenburg, S., Royal, S., Pipe, G., Lucassen, P., & Pirmohamed, M. (2007) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2006.02698.x · Cited by 625 · cited 1×
“In the USA and Canada, ADRs account for up to 30% of hospital admissions and can extend the length of stay [4].”
BackgroundDrug-Induced Liver Injury Network (DILIN) Prospective Study: Rationale, Design and Conduct
Fontana, R. J., Watkins, P. B., Bonkovsky, H. L., Chalasani, N., Davern, T., Serrano, J., & Rochon, J. (2009) · Drug Safety · doi:10.2165/00002018-200932010-00005 · Cited by 486
Self-citationSalo, P. M., Arbes, S. J., Jaramillo, R., Calatroni, A., Weir, C. H., Sever, M. L., Hoppin, J. A., Rose, K. M., Liu, A. H., Gergen, P. J., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.12.1071 · Cited by 351
Research works printed but not linked: 1
- Pawankar R, Canonica GW, ST Holgate ST, et al. The WAO White Book on Allergy (Update. 2013); World Allergy Organization 2013, pp. 57–61. (Accessed in January 2022)
Cited by
Chidiac, A. S., Buckley, N. A., Noghrehchi, F., & Cairns, R. (2023) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2023.2223959 · Cited by 215
Niu, H., Solís‐Muñoz, P., García‐Cortés, M., Sanabria‐Cabrera, J., Robles‐Díaz, M., Romero-Flores, R., Bonilla‐Toyos, E., Ortega‐Alonso, A., Pinazo-Bandera, J. M., Cabello, M. R., et al. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.107030 · Cited by 15
Lee, K. H., Jang, Y. J., Hwang, W. S., Kwon, K. S., Lee, W. Y., Kim, J., Kim, S. P., & Friedman, M. (2022) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-022-03705-y · Cited by 12
“cava food formulation that protected the lungs of mice against inflammatory allergic asthma might also help ameliorate the acute respiratory syndrome associated with the viral infection [31–33] as well as allergic manifestations associated with foods [34–38] and drugs [39].”
BackgroundThe role of regulatory T cells in preventing the development of drug hypersensitivity reactions
MacDonald, L., Mitchell, M., & Thomson, P. (2025) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000001083 · Cited by 3
(2023) · Reactions Weekly · doi:10.1007/s40278-023-43689-6
Metadata
- Authors
- Yeboah-Korang, A., Memon, A., Patel, N., Portocarrero-Castillo, A., Osman, A., Kleesattel, D., Lopez, C., Louissaint, J., Sherman, K., & Fontana, R.
- Affiliations
- University of Cincinnati Medical Center (US)
- MetroHealth (US)
- Columbia University Irving Medical Center (US)
- Michigan Medicine (US)
- Venue
- Digestive Diseases and Sciences
- Published
- 2022-02-04
- Volume
- 67
- Issue
- 11
- Pages
- 5262-5271
- ISSN
- 0163-2116 (ISSN-L)
- 1573-2568
- OpenAlex
- W4210607970
- Cited by
- 5
- References
- 38
- Citations by year
- 2025: 1 · 2023: 3 · 2022: 1
- FWCI
- 1.14
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Digestive Diseases and Sciences (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Association for the Study of Liver Diseases (AASLD Advanced/Transplant Hepatology Award)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Health Sciences › Medicine › Pharmacology (medical) › Drug-Induced Adverse Reactions
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Keywords
- idiosyncratic drug-induced liver injury, drug hypersensitivity, antimicrobial adverse effects, herbal and dietary supplements, anticancer agents, liver injury severity, liver transplantation, mortality, serum bilirubin, international normalized ratio, drug safety labeling, adverse drug reactions, adults, sex differences, comorbidities
- MeSH terms
- Adult, Antineoplastic Agents, Bilirubin, Drug Hypersensitivity, Exanthema, Female, Humans, Male, Chemical and Drug Induced Liver Injury, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Impact of Prior Drug Allergies on the Risk, Clinical Features, and Outcomes of Idiosyncratic Drug-Induced Liver Injury in Adults. https://app.cochat.ai/papers/10.1007/s10620-022-07403-0
- The paper
- Yeboah-Korang, A., Memon, A., Patel, N., Portocarrero-Castillo, A., Osman, A., Kleesattel, D., Lopez, C., Louissaint, J., Sherman, K., & Fontana, R. (2022). Impact of Prior Drug Allergies on the Risk, Clinical Features, and Outcomes of Idiosyncratic Drug-Induced Liver Injury in Adults. Digestive Diseases and Sciences. https://doi.org/10.1007/s10620-022-07403-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.